Nomura expects IPCA Labs shares to rally over 20% from current price, retains Buy call
Nomura has reiterated its 'Buy' rating on IPCA Laboratories, increasing the target price to Rs 1,750, implying a 20.19% upside in the stock price from its previous close of Rs 1,456
